HCPCS Level II code L8609 identifies an artificial cornea prosthetic device used in complex corneal replacement procedures. Artificial corneas are clinically significant as a vision-restoring option for patients with severe corneal disease or failed grafts who are not candidates for standard penetrating or lamellar keratoplasty. Nationally, device-level coding like L8609 is important for tracking utilization, device costs, and access to advanced ophthalmic care.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes how these payers typically handle coverage determinations for high-cost ophthalmic prostheses, administrative considerations tied to device billing, and common sites of service where implantation occurs.

Readers will find concise benchmarks and coverage context, an overview of billing and documentation considerations relevant to hospital outpatient departments and ambulatory surgical centers, and clinical context describing when an artificial cornea is indicated. Data not available in the input is noted where applicable, and the report focuses on national payer practices and policy-relevant observations rather than state-specific rules.